+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin use and risk of delirium in the critically ill



Statin use and risk of delirium in the critically ill



American Journal of Respiratory and Critical Care Medicine 189(6): 666-673



Delirium is common in intensive care unit (ICU) patients and is a predictor of worse outcomes and neuroinflammation is a possible mechanism. The antiinflammatory actions of statins may reduce delirium. To determine whether critically ill patients receiving statin therapy had a reduced risk of delirium than those not on statins. A prospective cohort analysis of data from consecutive ICU patients admitted to a UK mixed medical and surgical critical care unit between August 2011 and February 2012; the Confusion Assessment Method for ICU was used to determine the days each patient was assessed as being free of delirium during ICU admission. Delirium-free days, daily administration of statins, and serum C-reactive protein (CRP) were recorded. Four hundred and seventy consecutive critical care patients were followed, of whom 151 patients received statins. Using random-effects multivariable logistic regression, statin administration the previous evening was associated with the patient being assessed as free of delirium (odds ratio, 2.28; confidence interval, 1.01-5.13; P < 0.05) and with lower CRP (β = -0.52; P < 0.01) the following day. When the association between statin and being assessed as free of delirium was controlled for CRP, the effect size became nonsignificant (odds ratio, 1.56; confidence interval, 0.64-3.79; P = 0.32). Ongoing statin therapy is associated with a lower daily risk of delirium in critically ill patients. An ongoing clinical trial, informed by this study, is investigating if statins are a potential therapy for delirium in the critically ill.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911425

Download citation: RISBibTeXText

PMID: 24417431

DOI: 10.1164/rccm.201306-1150OC


Related references

Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Critical Care 17(1): R9-R9, 2015

Incidence and risk factors of delirium in critically ill patients after non-cardiac surgery. Chinese Medical Journal 123(8): 993-999, 2010

A meta-analysis of critically ill patients reveals several potential risk factors for delirium. General Hospital Psychiatry 36(5): 488-496, 2015

Sedative and analgesic medications: risk factors for delirium and sleep disturbances in the critically ill. Critical Care Clinics 22(2): 313-27, Vii, 2006

Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Medicine 35(11): 1886-1892, 2010

Early Identification of Subsyndromal Delirium in the Critically Ill: Don't Let the Delirium Rise!. Critical Care Medicine 44(3): 644-645, 2016

Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients. Critical Care Medicine 44(9): E809-E817, 2017

Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically Ill patients: a meta-analysis of randomized controlled trials. Journal of Cardiothoracic and Vascular Anesthesia 28(6): 1459-1466, 2015

Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk for delirium: a systematic review of quantitative evidence protocol. Jbi Database of Systematic Reviews and Implementation Reports 13(7): 83-92, 2016

Delirium and delirium management in critically ill patients. Medizinische Klinik, Intensivmedizin und Notfallmedizin 111(1): 14-21, 2016

Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study. Critical Care 15(5): R215-R215, 2012

Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalised patients: a review of data from prospective, randomised studies. Best Practice & Research. Clinical Anaesthesiology 26(3): 289-309, 2013

Risk of Pre-and Post-Operative Delirium and the Delirium Elderly At Risk (DEAR) Tool in Hip Fracture Patients. Canadian Geriatrics Journal 18(4): 212-216, 2016

Biomarkers associated with delirium in critically ill patients and their relation with long-term subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Critical Care 15(6): R297-R297, 2013

Delirium risk screening and haloperidol prophylaxis program in hip fracture patients is a helpful tool in identifying high-risk patients, but does not reduce the incidence of delirium. Bmc Geriatrics 11(): 39-39, 2012